BFM
FBIO icon

Boothbay Fund Management’s Fortress Biotech FBIO Stock Holding History

Boothbay Fund Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,345
Closed -$90K – 913
2019
Q4 		$90K Buy
+2,345
New +$60.2K 0.01% 767

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Boothbay Fund Management's FBIO Position: Q1 2020 in Review

Boothbay Fund Management sold out of Fortress Biotech (FBIO) in Q1 2020, closing a stake of 2,345 shares — an estimated $90K sold.

Boothbay Fund Management first reported a position in FBIO in Q4 2019 and held it in 1 quarter. The position peaked at $90K in Q4 2019. 55 funds tracked by Wall St. Rank hold FBIO as of Q1 2020.

  • Boothbay Fund Management reported no remaining Fortress Biotech position as of Q1 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 2,345 Fortress Biotech shares in Q1 2020, an estimated $90K.
  • Boothbay Fund Management first reported a position in Fortress Biotech in Q4 2019 and held it in 1 quarter.
  • Boothbay Fund Management's Fortress Biotech position peaked at $90K in Q4 2019.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.